Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$73.83BHealthcare Market cap, Sector
Novo Nordisk A/S
NVO$192.84BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 NVO
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsNVO
84B
C66
87A
C61
92A
B73
66C
D57
75B
D57
91A
B76
95A
B72
Side-by-side metrics
| Metric | JSLL.NS | NVO |
|---|---|---|
| Market cap | $73.83B | $192.84B Winner |
| P/E (TTM) | 33.3x | 10.7x Winner |
| EV/EBIT | 24.1x | 11.2x Winner |
| ROIC (TTM) | Winner: 39.15% | 32.2% |
| Gross margin | Winner: 88.58% | 81.85% |
| Net margin | 27.68% | 37.2% Winner |
| Revenue CAGR 5y | Winner: 57.81% | 21.72% |
| EPS CAGR 5y | Winner: 86.67% | 22.03% |
| Debt / Equity | Winner: 0.3x | 0.7x |
| Dividend yield | - | 3.99% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- EPS CAGR 5y86.67%vs 22.03%+75%
- Revenue CAGR 5y57.81%vs 21.72%+62%
- Debt / Equity0.3xvs 0.7x+62%
- ROIC (TTM)39.15%vs 32.2%+18%
NVO leads on
- P/E (TTM)10.7xvs 33.3x+68%
- Market cap$192.84Bvs $73.83B+62%
- EV/EBIT11.2xvs 24.1x+54%
- Net margin37.2%vs 27.68%+26%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.